breast cancers - Robuta Search

https://pubmed.ncbi.nlm.nih.gov/27617288/ Portraying breast cancers with long noncoding RNAs Evidence is emerging that long noncoding RNAs (lncRNAs) may play a role in cancer development, but this role is not yet clear. We performed a genome-wide... breast cancers long rnas https://www.news-medical.net/news/20251201/Study-highlights-a-rising-incidence-of-breast-cancers-in-younger-women.aspx Study highlights a rising incidence of breast cancers in younger women Dec 1, 2025 - A study of data from seven outpatient facilities in the New York region found that 20-24% of all the breast cancers diagnosed during an 11-year period were... breast cancers study highlights rising incidence https://www.cancer.gov/types/breast/research/t-dm1 For Some Breast Cancers, New Drug May Be Treatment Option - NCI Results from an international clinical trial suggest that women with metastatic, HER2-positive breast cancer that is no longer responding to the targeted... breast cancers new drug may be https://www.wikidata.org/wiki/Q71116140 MT-MMP expression and localisation in human lung and breast cancers - Wikidata scientific article published on 01 April 1996 in human breast cancers mt mmp expression https://www.aafp.org/pubs/afp/issues/2006/0801/p490.html Mammography Results in Overdiagnosis of Breast Cancers | AAFP mammography results breast cancers overdiagnosis aafp https://www.cancer.gov/news-events/press-releases/2018/tailorx-breast-cancer-chemotherapy TAILORx finds no chemotherapy benefit for most early breast cancers - NCI Findings from the TAILORx clinical trial show chemotherapy does not benefit most women with early breast cancer. The new data, released at the 2018 ASCO annual... chemotherapy benefit breast cancers finds https://www.sciencedaily.com/releases/2016/04/160421085230.htm Study finds explanation for some treatment-resistant breast cancers | ScienceDaily Investigators have identified gene alterations that may explain why triple-negative breast cancer is resistant to most existing treatments, and suggests that a... study finds breast cancers explanation treatment resistant https://www.sciencedaily.com/releases/2018/10/181015100448.htm 3D mammography detected 34 percent more breast cancers in screening | ScienceDaily After screening 15,000 women over a period of five years, a major clinical study in Sweden has shown that 3D mammography, or breast tomosynthesis, detects over... breast cancers mammography detected percent https://www.scirp.org/journal/paperinformation?paperid=17400 Cervix and breast cancers in Oujda city in Eastern Morocco: Determinants and risk factors Study on cervical and breast cancer in Eastern Morocco, examining social determinants, risk factors, and the importance of early detection and treatment.... breast cancers https://anthro.utah.edu/publications/webster_5-19-2021.php Unique evolutionary trajectories of breast cancers with distinct genomic and spatial heterogeneity... breast cancers https://tumorablations.com/ Metatstic Breast Cancer Treatment | Thermal Ablation Therapy | Surgical Treatments for Bone Cancers... Five Points Cancer Care offers advanced treatments for metastatic breast cancer, bone cancers, and liver tumors, including thermal ablation and surgical... breast cancer treatment thermal ablation https://experts.umn.edu/en/publications/mutations-in-the-arginine-rich-protein-gene-in-lung-breast-and-pr/ Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous... https://www.kcl.ac.uk/news/new-antibody-restricts-the-growth-of-aggressive-and-treatment-resistant-breast-cancers New antibody restricts the growth of aggressive and treatment-resistant breast cancers | King's... A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed by scientists. https://experts.umn.edu/en/publications/soluble-e-cadherin-activates-her-and-iap-family-members-in-her2-a/ Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers -... https://pubmed.ncbi.nlm.nih.gov/27626701/ CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers CDCP1, a transmembrane noncatalytic receptor, the expression of which has been associated with a poor prognosis in certain epithelial cancers, was found to be... https://pmc.ncbi.nlm.nih.gov/articles/PMC2602616/ Hereditary breast and ovarian cancers - PMC hereditary breast ovarian cancers pmc https://www.news-medical.net/news/20240119/Insilico-Medicine-leverages-AI-to-identify-promising-new-target-for-breast-and-gynecological-cancers.aspx Insilico Medicine leverages AI to identify promising new target for breast and gynecological cancers Jan 20, 2024 - Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven drug discovery company, recently published an early research... https://news.cancerresearchuk.org/2024/01/25/talazoparib-brca-genes-targeted-advanced-breast-cancer-treatment-nhs/ NHS offers first drug targeting advanced breast cancers driven by BRCA gene mutations - Cancer... Jan 21, 2026 - Around 300 people in England can receive talazoparib, which can stop advanced breast cancers with BRCA gene mutations growing for longer. https://internalmedicine.wustl.edu/drug-in-clinical-trials-for-breast-cancer-could-also-treat-some-blood-cancers/ Drug in clinical trials for breast cancer could also treat some blood cancers - John T. Milliken... Jan 16, 2025 - Researchers are working with industry toward a clinical trial for blood cancer patients Two new studies led by researchers at Washington University School of... https://www.urmc.rochester.edu/cancer-institute/cancers/breast/support-survivorship Support & Survivorship - Breast Cancer - Cancers We Treat - Wilmot Cancer Institute - URochester... cancers we treat support survivorship breast wilmot https://tobias-lib.ub.uni-tuebingen.de/xmlui/handle/10900/75777 BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers https://medicine.iu.edu/news/2023/10/black-women-breast-cancer-discovery IU cancer center researchers identify biology behind aggressive breast cancers in Black women Researchers at Indiana University Melvin and Bren Simon Comprehensive Cancer Center are unlocking the biology behind aggressive breast cancers in Black women. https://professional.heart.org/en/science-news/impact-of-hormonal-therapies-for-treatment-of-hormone-dependent-cancers-breast-and-prostate-on-the-c Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on... https://epub.ub.uni-muenchen.de/33135/ Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC)... https://drum.lib.umd.edu/items/b43331b9-0dfc-4fc6-be40-50cbc1c0a7ef Test Could Detect Breast Cancers Earlier in Young, High-risk African-American Women Certain cancer signaling pathways that are activated in aggressive cancer can be detected very early, even in precancerous cells, among young African-American... https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2014.00042/full Frontiers | Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and... Poly(ADP-ribose) polymerase inhibitors (PARPi) have shown clinical activity in patients with germline BRCA1/2 mutation (gBRCAm)-associated breast and ovarian... https://camrt.my.site.com/CPBase__item?id=a10OK00000J4CHPYA3 Breast Imaging: Dose and Missed Cancers | Canadian Association of Medical Radiation Technologists /... breast imaging https://news.cancerresearchuk.org/2025/05/13/partner-brca-breast-cancer-treatment-olaparib-chemotherapy/ Partnering olaparib with chemotherapy helps treat BRCA breast cancers - Cancer Research UK - Cancer... May 15, 2025 - Our PARTNER trial has found a new way to treat inherited breast cancers linked to BRCA mutations, and reported 100% survival. https://www.frontiersin.org/research-topics/25458/identification-of-genetic-changes-and-targeted-therapies-in-breast-and-ovarian-cancers/magazine Identification of Genetic Changes and Targeted Therapies in Breast and Ovarian Cancers | Frontiers... Recent advances in our understanding of the molecular biology of cancer in conjunction with the advent of next generation sequencing (NGS) have led to the... targeted therapies https://www.luci.lu.se/en/kristin-johnson/publication/a3b39517-a4cc-4196-9913-76b948bd471f Classification of interval cancers on digital breast tomosynthesis compared to digital mammography... digital breast tomosynthesis classification interval cancers https://www.drkatherinegeddes.com/ Dr Katherine Geddes | Bayside & SE Suburbs | Breast & GI Cancers A unique and personalised oncology practice catered to your individual needs. Dr Katherine Geddes Oncology is located across Bayside, Mornington Peninsula and... dr katherine geddes bayside se https://www.cirm.ca.gov/our-progress/awards/reversal-dysregulated-myelopoiesis-breast-cancers-and-cancer-stem-cells-boost-antitumor-immunotherapy/ Reversal of dysregulated myelopoiesis in breast cancers and cancer stem cells to boost antitumor... https://pure.psu.edu/en/publications/a-radio-genomics-approach-for-identifying-high-risk-estrogen-rece/ A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on... https://pubmed.ncbi.nlm.nih.gov/22495314/ The clonal and mutational evolution spectrum of primary triple-negative breast cancers Primary triple-negative breast cancers (TNBCs), a tumour type defined by lack of oestrogen receptor, progesterone receptor and ERBB2 gene amplification,... https://pubmed.ncbi.nlm.nih.gov/25314053/ Lactose intolerance and risk of lung, breast and ovarian cancers: aetiological clues from a... In this large cohort study, people with lactose intolerance, characterised by low consumption of milk and other dairy products, had decreased risks of lung,... https://eprints.ncl.ac.uk/82478 Pulses and carcinogenesis: potential for the prevention of colon, breast and other cancers -... for the https://www.sciencedaily.com/releases/2007/06/070603215341.htm MRI Detects Cancers Missed By Mammography In Breast Cancer Patients | ScienceDaily A unique examination of one treatment center's use of magnetic resonance imaging (MRI) in new breast cancer patients has found MRI to be superior to... breast cancer mri detects cancers missed https://case.edu/news/research-team-discovers-key-mechanisms-inhibit-triple-negative-breast-cancers Research team discovers key mechanisms to inhibit triple negative breast cancers | CWRU Newsroom |... May 22, 2025 - Findings could lead to life-saving treatments to fight tumor metastasis A team of researchers from Cleveland Clinic and Case Western Reserve School of... https://www.cancer.org/cancer/types/breast-cancer/living-as-a-breast-cancer-survivor/second-cancers-after-breast-cancer.html Second Cancers: Developing a New Cancer after Breast Cancer | American Cancer Society Breast cancer survivors are often concerned about facing cancer again. Some breast cancer survivors develop a new, unrelated cancer called a second cancer. a new second cancers developing breast https://sysbiowiki.soe.ucsc.edu/node/584 A comprehensive Pan-Cancer molecular study of gynecologic and breast cancers | Systems Biology Group https://liu.diva-portal.org/smash/record.jsf?pid=diva2:269660 Interval cancers in breast cancer screening : mistakes by the radiolgists or a special group of... https://dash.harvard.edu/entities/publication/73120378-9af7-6bd4-e053-0100007fdf3b Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an... Introduction: Breast Cancer Prevention Trial (BCPT) and Multiple Outcomes of Raloxifene (MORE) data have been interpreted to indicate that tamoxifen reduces... https://research.birmingham.ac.uk/en/publications/is-the-3-year-breast-screening-interval-too-long-occurrence-of-in/ Is the 3 year breast screening interval too long? Occurrence of interval cancers in the NHS breast... https://pubmed.ncbi.nlm.nih.gov/19570649/ Why pesticides could be a common cause of prostate and breast cancers in the French Caribbean... Prostate and breast cancers have become very frequent in Martinique. We previously conducted a multifactorial analysis in the French Caribbean Island,... https://learningenglish.voanews.com/a/a-23-2005-10-25-voa3-83125442/124571.html Studies Support Wider Use of a Drug for Some Breast Cancers But there are questions about possible heart risks from Herceptin, which targets an aggressive form of cancer of a studies support wider use https://pubmed.ncbi.nlm.nih.gov/27038352/?dopt=Abstract The association of soy food consumption with the risk of subtype of breast cancers defined by... Soy food intake has previously been associated with reduced breast cancer risk. Epidemiological evidence for subgroups of breast cancer, particularly by... https://magazine.alumni.ubc.ca/podcasts/risky-genes-uncovering-genetic-basis-breast-and-ovarian-cancers Risky genes: Uncovering the genetic basis of breast and ovarian cancers | UBC Magazine Hear from Dr. Steven Narod, a leading expert in breast and ovarian cancer genetics research. https://adisinsight.springer.com/trials/700319003?error=cookies_not_supported&code=7fd79f1f-f2de-41a8-8b43-4cf5dfb4513e Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to... This is a single arm, open-label, lead in phase Ib dose confirmation, followed by phase II study with 2 parallel study cohorts. The study contains lead-in dose https://pubmed.ncbi.nlm.nih.gov/26434877/ Differences in Prognostic Factors between Early and Late Recurrence Breast Cancers Tumor size, p53 and LN metastasis are the most important risk factors for distance recurrence especially in early recurrence and also between of them, p53 is... prognostic factors differences https://www.sciencedaily.com/releases/2012/09/120923145058.htm Genomic similarities between breast cancer and ovarian cancers revealed; Findings could aid new... One subtype of breast cancer shares many genetic features with high-grade serous ovarian cancer, a cancer that is very difficult to treat, according to... https://secure.patientresource.com/ Patient Resource - Cancer Patient Education: Lung, Prostate, Blood Cancers, Breast, Thyroid,... Patient Resource - Cancer Patient Education: Lung, Prostate, Blood Cancers, Breast, Thyroid, Caregivers content from Patient Resource - patient resource cancer education blood cancers lung prostate https://carolinemfr.blogspot.com/2009/07/tale-of-two-breast-cancers-from.html Caroline's Breast Cancer Blog: The tale of two breast cancers from Consumer Reports But first my morning started with trauma: The coffee maker didn't work. I am suffering without but will buy a cup on my way to work. Later t... breast cancer blog tale of two https://about.uq.edu.au/experts/project/37237 Improving the clinical management of familial breast cancers with genomics | Project | UQ Experts https://www.imperial.ac.uk/news/249573/new-ai-tool-detects-13-more New AI tool detects up to 13% more breast cancers than humans alone | Imperial News | Imperial... A new AI tool from Kheiron Medical Technologies and Imperial College London can detect up to 13% more breast cancers than humans in breast screenings. https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-why-some-breast-cancers-respond-better-than-others-to-the-drugs-letrozole-or-anastrozole A study looking at why some breast cancers respond better than others to letrozole or anastrozole This study looked at blood and tissue samples to understand more about why letrozole and anastrozole helped some people with breast cancer more than others. https://www.sciencenews.org/article/ominous-signals-genes-may-identify-worst-breast-cancers Ominous signals: Genes may identify the worst breast cancers Aug 8, 2019 - By using a technology that reveals patterns of gene activity in tumor cells, researchers can detect breast cancers that are likely to spread and become deadly. the worst ominous signals genes may